A series of forty-seven quinoxaline derivatives, 2-(XYZC 6 H 2 CH@N-NH)-quinoxalines, 1, have been synthesized and evaluated for their activity against four cancer cell lines: potent cytotoxicities were found (IC 50 ranging from 0.316 to 15.749 lM). The structure-activity relationship (SAR) analysis indicated that the number, the positions and the type of substituents attached to the aromatic ring are critical for biological activity. The activities do not depend on the electronic effects of the substituents nor on the lypophilicities of the molecules. A common feature of active compounds is an ortho-hydroxy group in the phenyl ring. A potential role of these ortho-hydroxy derivatives is as N,N,O-tridentate ligands complexing with a vital metal, such as iron, and thereby preventing proliferation of cells. The most active compound was (1: X,Y = 2,3-(OH) 2 , Z = H), which displayed a potent cytotoxicity comparable to that of the reference drug doxorubicin.
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As indicated by the estimated costs of cancer in 2007 of $226.8 billion, 1 and by the 7.6 million cancer world-wide deaths (13% of all deaths) in 2008, 2 cancer is clearly a major concern. The need for effective treatment and new anticancer agents is of paramount importance.
We have previously reported on the biological activities of hydrazone derivatives of a number of different heteroaromatic compounds.
3-10 Now we wish to report the results of an evaluation of the anti-cancer activities of a series of hydrazone-quinoxaline derivatives, 2-XYZC 6 H 4 -CH@N-NH)-quinoxaline, 1. Quinoxaline compounds have a wide range of uses, mainly as biologically active compounds, but also as dyestuffs. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The biological uses of quinoxaline compounds include as antibacterial, antitubercular, antimicrobial, antifungal, antimalarial, anti-inflammatory, antileishmanial, and antitumor agents, as well as herbicides, insecticides [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The biological activities of hydrazone derivatives of heteroaromatic compounds have also been well reported, [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] with anticancer activities being of significant interest. [24] [25] [26] [27] [28] [29] [30] [31] Our report, however, is the first of the use of hydrazinyl-quinoxalines of the type, 2-(XYZC 6 H 3 -CH@NANH)-quinoxaline, 1, as anticancer agents. Compounds 1 were obtained by molecular hybridization, see Scheme 1. The quinoxalinyl-hydrazones, 2-(XYZC 6 H 2 CH@NANH)-quinoxalines, 1, were synthesized from reactions of 2-hydrazinylquinoxaline, 3, and arenecarbaldehydes, in 55-96% yields, as shown in Scheme 1. As can be seen from Table 1 , compounds with a wide range of substituents were prepared and studied.
Characterization of the compounds 1 was generally achieved from NMR and IR spectral data. In the 1 H NMR spectra, the signal for the N@CH proton was in the region 7.98-8.54 ppm, while the N-H and N@C stretching vibrations in the IR spectra were at 3400-3491 and 1565-1612 cm
À1
, respectively. The spectral data are included in the Supplementary section, along with melting points and yields of the derivatives.
The crystal structures of (1: X = Y = Z = H) and the mono-haloderivatives, (1: X = 2-, 3-, 4-Br, 2-, 3-, 4-Cl; Y = Z = H) have been reported. 32 As is discussed below, (1: X = Y = Z = H) and the mono-halo derivatives are all, at best, poorly active. Thus, the structure determination of a reasonably active compound was considered to be a useful exercise as it would indicate any conformational differences between active and non-active compounds. Suitable crystals of an acetone solvate of (1: X,Y = (2,4-(OH) 2 , Z = H), an active compound, were grown from an acetone solution. The presence of nitrogen and hydroxyl groups in (1: X,Y = (2,4-(OH) 2 , Z = H) allows for various intra-and inter-molecular interactions, see Table 2 Figure 3b shows the orientation of two of these columns through the crystallographic cell. The strongest interaction, the N3-HN3Á Á ÁN4 hydrogen bond, generates C(6) chains. 38 The N3-HN3Á Á ÁN4 hydrogen bond together with O2-H2Á Á ÁO3 and weaker C5-H5Á Á ÁN1, C15-H15Á Á ÁO1 and C16-H16CÁ Á ÁO2 hydrogen bonds forms a series of rings, R . 38 The second major subset is formed from alternating stronger and weaker p(pyridine)-p(pyridine) stacking interactions, see Figure 3c . Table 2 contains details of the interactions. There is an additional, but less important, intermolecular It is striking that all but one of these compounds, (1: X,Y = 2,3-Cl 2 , Z = H), contained a 2-hydroxy group, with a range of other substituents, both electron releasing and withdrawing, also present. The compounds with 2-hydroxy substituents have low log P values, but so do other . Hence a low lypophilicity is not a requirement for activity. The majority of the active compounds from the first phase were selected for further evaluation against the four human cancer cell lines: OVCAR-8 (human ovary), SF-295 (glioblastoma), HCT-116 (colon) and HL-60 (leukemia), using the MTT assay. The concentrations that induce 50% inhibition of cell growth (IC 50 ) in lg/mL are reported in Table 3 .
Compound (1: X,Y = 2,3-(OH) 2 , Z = H) exhibited the best results against all four cancer lines in the second phase of the study. Other active compounds in the second phase were (1: X = 2-OH, Y = Z = H) and (1: X = 2-OH, Y = 5-NO 2 , Z = H).
In looking for factors why the 2-hydroxy-substituted compounds are active, the possibility of coordination with vital metal centres cannot be ignored. There are various reports in the literature of (pyridin-2-yl)NHN = CH-C 6 H 4 OH-2 and related compounds acting as tridentate, N,N,O-ligands to metal centres. Indeed, crystal structures of complexes with VO(IV), 40 VO(V), 41 MoO 2 (VI), 42 
Table 3
Cytotoxic activity of selected compounds [IC 50 (lM)] on tumor cell lines Table 2 for symmetry operations and geometric parameters.
Ru(III), 43 Fe(III), 44 Cu(II), [45] [46] [47] [48] [49] Zn(II), 50 Mn, [51] [52] [53] mixed Mn-lanthanide, 53 and tin(IV) 54 have all been reported to contain these N,N,Oligands. While the emphasis of many of these reports were on non-biological aspects, some did highlight biological activities, OK the anticancer activity, 49 the antimicrobial activity 46 and interactions with DNA 44 of Cu(II) complexes were all mentioned. While most of these complexes involve pyridin-2-yl species, the Russian work 47 shows that quinolin-2-yl derivatives also form these complexes. Whilst quinoxaline is considerably less basic than either pyridine or quinoline, as shown by the pK a values, 55 complexes of quinoxalines with transition metals have been known for many years, see Refs. 56-58. The report by Lakshmi et al. on the antimicrobial activities of oxovanadium(IV) complexes of 3-hydroxy-2-(2-hydroxypheny-lCH@NANH)-quinoxaline (or its carbonyl tautomer) and related ligands is particular pertinent to our work. 59 Lakshmi et al.'s compounds were characterized spectroscopically and by elemental analyses, however no crystal structure was determined and so the precise binding mode of the ligand to the metal centre remains unknown. A theoretical treatment of the bonding between quinoxaline and copper ions was very recently reported 37 and provides a good basis for the interactions of metals generally with quinoxaline ligands. Of all the metals mentioned above, iron is particularly relevant. Iron is very important in DNA synthesis, adenosine triphosphate production and cell replication. Studies have demonstrated that cancer cells are susceptible to iron complexing ligands. 60 Acylhydrazones have shown potential as iron chelators. 61 Chelation therapy has demonstrated that effective iron regulation is antitumor Comparison of the activities of 1 and the bioisosteric series, 4-(aryl-CH@NANH)-7-chloro-quinoline, 4
63-65 is of interest. As shown by the comparison of activities in Scheme 3, the quinoxaline compounds are more active than the corresponding 7-chloroquinoline derivatives.
In this work, we report the cytotoxicity activity of a series of quinoxaline derivatives, which have been evaluated against four cancer cell lines. The SAR of these compounds indicated that the positions and the type of substituents in the phenyl ring are critical for the biological activity. The compound (1: X = Y = 2,3-(OH) 2 , Z = H) displayed a potent cytotoxicity activity compared to the reference drug doxorubicin.
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